Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203775 · ClinicalTrials.gov registry record · NA
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
A NA study, sponsored by University of Connecticut.
- Terminated
- Registry status
- NA
- Development phase
NCT00203775 is a NA study that was terminated before completion, run by University of Connecticut.
The verdict
NCT00203775, a NA study, was terminated before completion, sponsored by University of Connecticut.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
Interventions
- DRUG risperidone
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-07 |
| Est. Completion | 2004-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203775
The ClinicalTrials.gov registry entry for NCT00203775 describes a study currently listed as terminated, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which risperidone is the first listed.
NCT00203775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00203775 about?
NCT00203775 is a clinical study titled "Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates". This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
What is the current status of trial NCT00203775?
This trial is currently terminated. It is a NA study. The study started on 2002-07. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00203775?
The interventions under investigation include: risperidone (DRUG).
Who is sponsoring clinical trial NCT00203775?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.